The False Claims Act (FCA) is the federal government’s most powerful fraud-fighting weapon, but in recent years, private relators, and even some DOJ prosecutors, have wielded it to punish conduct never contemplated to be FCA violations. DOJ’s new management, however, have shown signs of pulling back the reins on expansive qui tam and government enforcement. Two nationally recognized FCA experts will evaluate DOJ’s intentions to reduce frivolous qui tam claims and curtail suits based on violation of agency guidance, and will also discuss whether the FCA is a suitable tool for DOJ’s role in combating opioid diversion and abuse.